tirzepatide for long covid Can a GIP/GLP-1 dual receptor agonist help treat COVID? A new nationwide clinical trial led by scientists at the Scripps Research Translational Institute is putting that question to the test. The RECOVER's 2nd Round of Long

Severe, persistent stomach pain needs urgent clinical advice

As treatment continues and the dosage increases, the medications appetite-regulating effects become more stable

[2][8] When vomiting is a concern: Dehydration repeated vomiting prevents adequate fluid intake, which can become medically significant Electrolyte imbalance loss of fluids and stomach acid disrupts sodium, potassium, and chloride levels Inability to take other medications vomiting can prevent absorption of other essential drugs Pancreatitis (rare) severe abdominal pain accompanied by vomiting may indicate pancreatic inflammation, a rare but serious adverse event [6][8] Bowel obstruction (rare) extremely slowed gut motility in susceptible individuals can, in rare cases, progress to obstruction [2] The Mayo Clinics tirzepatide prescribing information flags severe abdominal pain, persistent vomiting, and signs of dehydration as reasons to seek immediate medical attention

B12 supplementation deserves special mention

Bennetts partner Braiden F